Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 107 results found. Search for [ Novavax ]

Results 60 to 80 of 107
BusinessToday.In
New Delhi, August 6, 2020
U.S. crude oil stockpiles fell sharply last week as refining rates hit their highest since March, while gasoline and distillate inventories rose, the Energy Information Administration said; Novavax Inc has entered a supply and license agreement with the Serum Institute of India for the development and commercialisation of its COVID-19 vaccine candidate; Food brands today are riding the wave of 'immunity boosting products' led by consumer demand. Watch this and more news on News Blast.Also Read: RBI keeps repo rate unchanged at 4%, maintains status quo


Reuters
August 6, 2020
On Tuesday, Novavax reported that its experimental Covid-19 vaccine produced high levels of antibodies against the novel coronavirus in a small, early-stage clinical trial, and that it could start a large pivotal Phase III trial as soon as late September


BusinessToday.In
New Delhi, August 6, 2020
Coronavirus impact: Banks, NBFCs to face asset quality distress, says ICRAIndia's banks and non-banking financial companies (NBFCs) will continue to face elevated asset quality risks even as most of them reported a decline in the loans under moratorium provided by the Reserve bank of India (RBI) to borrowers on their loan repayments, as per a latest report. This was attributed to the impact of the coronavirus pandemic on borrowers' repayment capabilities.US crude oil stockpiles tumble sharp...


Reuters
August 5, 2020
Brazil's federal government has said it will invest 1.9 billion reais ($355 million) to process and produce the AstraZeneca vaccine


Reuters
August 5, 2020
The company said it could start a large pivotal Phase III trial as soon as late September, and on a conference call added that it could produce 1 billion to 2 billion doses of the vaccine in 2021


Reuters
July 31, 2020
The indictment states the Chinese hackers \"conducted reconnaissance\" against the computer network of a Massachusetts biotech firm known to be working on a coronavirus vaccine in January


BusinessToday.In
July 28, 2020
Coronavirus vaccine news: Serum Institute of India CEO Adar Poonawalla had earlier stated that the company would reserve 50 per cent of the vaccine doses for use in India


BusinessToday.In
July 27, 2020
Although PubG videogame has been developed by a subsidiary of South Korean video game company Bluehole, it is also backed by China's most valuable internet major Tencent


Reuters
July 27, 2020
In April, Moderna had received $483 million from the U.S. federal agency that funds disease-fighting technology, when the experimental vaccine was in an early-stage trial conducted by the U.S. National Institutes of Health


BusinessToday.In
July 8, 2020
Coronavirus vaccine update: Twelve hospitals have been chosen for COVAXIN trials in the country. Bharat Biotech's COVAXIN is undergoing quality and safety tests before the doses are administered to volunteers


PTI
July 8, 2020
During blood purification therapy, the patient's blood passes through the Oxiris filter set, where it can adsorb inflammatory mediators, and remove fluid, electrolytes and uremic toxins, before returning the patient's blood to the body, Baxter India said


Reuters
July 7, 2020
The announcement follows a $456 million investment in Johnson & Johnson's vaccine candidate in March, a $486 million award to Moderna Inc in April, and up to $1.2 billion in support in May for AstraZeneca's vaccine being developed with Oxford University


BusinessToday.In
July 7, 2020
The Central Drug Standard Control Organisation--the office of Drug Controller General of India--has granted permission to initiate Phase-1 and Phase-2  clinical trial of Covaxin. A total of 12 institutes have been selected to conduct clinical trials for Covaxin


BusinessToday.In
July 2, 2020
Coronavirus Vaccine Latest News: With the news of the Oxford University-AstraZeneca vaccine in its last stage of clinical trials, hopes are high for an earlier than expected arrival of a COVID-19 vaccine


Reuters
July 2, 2020
BioNTech said testing of two dosages of its BNT162b1 drug on 24 healthy volunteers showed that after 28 days they had developed higher levels of COVID-19 antibodies than typically seen in infected people


E Kumar Sharma
July 1, 2020
Bharat Biotech isn't committing a timeline, but considering the necessary processes, and if COVAXIN does not fail at any stage, the earliest it could hit the market is late 2021


BusinessToday.In
June 29, 2020
With the news of the Oxford University-AstraZeneca vaccine in its last-stage trial, the world is hopeful of an earlier than expected arrival of a COVID-19 vaccine


Reuters
June 25, 2020
Even with no existing approved vaccines, CEPI is already getting manufacturing and supply chains lined up in a quest to ensure coronavirus vaccines are distributed equitably around the globe


PB Jayakumar
New Delhi, June 9, 2020
Whether India develops a Covid-19 vaccine/drug or not, Indian companies will be preferred partners for global pharma to make and distribute the life-saving drug globally


BusinessToday.In
New Delhi, June 4, 2020
COVID 19 Vaccine News India: The government has now permitted a few relaxations to the Drugs and Cosmetics Act, 1940


PAGES 4 OF 6  12345